Genmab Announces Johnson & Johnson Decision Regarding HexaBody®-CD38
Go back to Genmab Announces Johnson & Johnson Decision Regarding HexaBody®-CD38| (NASDAQ: GMAB) | Delayed: 33.83 +0.54 (1.62%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $33.29 | 52 Week High | $ | |||
| Open | $34.04 | 52 Week Low | $ | |||
| Day High | $34.50 | P/E | N/A | |||
| Day Low | $33.74 | EPS | $ | |||
| Volume | 538,076 | |||||
| (NASDAQ: GMAB) | Delayed: 33.83 +0.54 (1.62%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $33.29 | 52 Week High | $ | |||
| Open | $34.04 | 52 Week Low | $ | |||
| Day High | $34.50 | P/E | N/A | |||
| Day Low | $33.74 | EPS | $ | |||
| Volume | 538,076 | |||||

